Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2005 2
2006 4
2007 1
2009 3
2010 7
2011 8
2012 3
2013 3
2014 4
2015 2
2016 6
2017 1
2018 4
2019 7
2020 4
2021 4
2022 6
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Results by year

Filters applied: . Clear all
Page 1
GD3 ganglioside is a promising therapeutic target for glioma patients.
Hein V, Baeza-Kallee N, Bertucci A, Colin C, Tchoghandjian A, Figarella-Branger D, Tabouret E. Hein V, et al. Among authors: colin c. Neurooncol Adv. 2024 Mar 19;6(1):vdae038. doi: 10.1093/noajnl/vdae038. eCollection 2024 Jan-Dec. Neurooncol Adv. 2024. PMID: 38590763 Free PMC article. Review.
Combination drug screen targeting glioblastoma core vulnerabilities reveals pharmacological synergisms.
Ariey-Bonnet J, Berges R, Montero MP, Mouysset B, Piris P, Muller K, Pinna G, Failes TW, Arndt GM, Morando P, Baeza-Kallee N, Colin C, Chinot O, Braguer D, Morelli X, André N, Carré M, Tabouret E, Figarella-Branger D, Le Grand M, Pasquier E. Ariey-Bonnet J, et al. Among authors: colin c. EBioMedicine. 2023 Sep;95:104752. doi: 10.1016/j.ebiom.2023.104752. Epub 2023 Aug 10. EBioMedicine. 2023. PMID: 37572644 Free PMC article.
Deciphering the Action of Neuraminidase in Glioblastoma Models.
Baeza-Kallee N, Bergès R, Hein V, Cabaret S, Garcia J, Gros A, Tabouret E, Tchoghandjian A, Colin C, Figarella-Branger D. Baeza-Kallee N, et al. Among authors: colin c. Int J Mol Sci. 2023 Jul 19;24(14):11645. doi: 10.3390/ijms241411645. Int J Mol Sci. 2023. PMID: 37511403 Free PMC article.
Clinico-pathological and epigenetic heterogeneity of diffuse gliomas with FGFR3::TACC3 fusion.
Métais A, Tauziède-Espariat A, Garcia J, Appay R, Uro-Coste E, Meyronet D, Maurage CA, Vandenbos F, Rigau V, Chiforeanu DC, Pallud J, Senova S, Saffroy R, Colin C, Edjlali M, Varlet P, Figarella-Branger D; Biopathology RENOCLIP-LOC network. Métais A, et al. Among authors: colin c. Acta Neuropathol Commun. 2023 Jan 16;11(1):14. doi: 10.1186/s40478-023-01506-z. Acta Neuropathol Commun. 2023. PMID: 36647073 Free PMC article.
MiR-1248: a new prognostic biomarker able to identify supratentorial hemispheric pediatric low-grade gliomas patients associated with progression.
Catanzaro G, Besharat ZM, Carai A, Jäger N, Splendiani E, Colin C, Po A, Chiacchiarini M, Citarella A, Gianno F, Cacchione A, Miele E, Diomedi Camassei F, Gessi M, Massimi L, Locatelli F, Jones DTW, Figarella-Branger D, Pfister SM, Mastronuzzi A, Giangaspero F, Ferretti E. Catanzaro G, et al. Among authors: colin c. Biomark Res. 2022 Jun 17;10(1):44. doi: 10.1186/s40364-022-00389-x. Biomark Res. 2022. PMID: 35715818 Free PMC article.
A2B5 Expression in Central Nervous System and Gliomas.
Figarella-Branger D, Colin C, Baeza-Kallee N, Tchoghandjian A. Figarella-Branger D, et al. Among authors: colin c. Int J Mol Sci. 2022 Apr 23;23(9):4670. doi: 10.3390/ijms23094670. Int J Mol Sci. 2022. PMID: 35563061 Free PMC article. Review.
Rosette-forming glioneuronal tumours are midline, FGFR1-mutated tumours.
Appay R, Bielle F, Sievers P, Barets D, Fina F, Boutonnat J, Adam C, Gauchotte G, Godfraind C, Lhermitte B, Maurage CA, Meyronet D, Mokhtari K, Rousseau A, Tauziède-Espariat A, Tortel MC, Uro-Coste E, Burel-Vandenbos F, Chotard G, Pesce F, Varlet P, Colin C, Figarella-Branger D. Appay R, et al. Among authors: colin c. Neuropathol Appl Neurobiol. 2022 Aug;48(5):e12813. doi: 10.1111/nan.12813. Epub 2022 Mar 23. Neuropathol Appl Neurobiol. 2022. PMID: 35293634
Genomic analysis of paired IDHwt glioblastomas reveals recurrent alterations of MPDZ at relapse after radiotherapy and chemotherapy.
Chanez B, Appay R, Guille A, Lagarde A, Colin C, Adelaide J, Denicolai E, Jiguet-Jiglaire C, Bequet C, Graillon T, Boissonneau S, Nanni-Metellus I, Dufour H, Figarella-Branger D, Chinot O, Tabouret E. Chanez B, et al. Among authors: colin c. J Neurol Sci. 2022 May 15;436:120207. doi: 10.1016/j.jns.2022.120207. Epub 2022 Feb 24. J Neurol Sci. 2022. PMID: 35259554
[The 2021 WHO classification of tumours of the central nervous system].
Figarella-Branger D, Appay R, Metais A, Tauziède-Espariat A, Colin C, Rousseau A, Varlet P. Figarella-Branger D, et al. Among authors: colin c. Ann Pathol. 2022 Oct;42(5):367-382. doi: 10.1016/j.annpat.2021.11.005. Epub 2021 Dec 2. Ann Pathol. 2022. PMID: 34865882 French.
Low-grade epilepsy-associated neuroepithelial tumours with a prominent oligodendroglioma-like component: The diagnostic challenges.
Métais A, Appay R, Pagès M, Gallardo C, Silva K, Siegfried A, Perbet R, Maurage CA, Scavarda D, Fina F, Uro-Coste E, Riffaud L, Colin C, Figarella-Branger D; contributors of the Biopathology RENOCLIP-LOC network. Métais A, et al. Among authors: colin c. Neuropathol Appl Neurobiol. 2022 Feb;48(2):e12769. doi: 10.1111/nan.12769. Epub 2021 Nov 4. Neuropathol Appl Neurobiol. 2022. PMID: 34551121
68 results